Advanced search
Publication Cover
Scandinavian Cardiovascular Journal Volume 58, 2024 - Issue 1
Submit an article Journal homepage
92
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

A reply to the letter to the editor “Common practice of underreporting and downplaying adverse events and exaggerating benefits in patients undergoing percutaneous coronary intervention of chronic total occlusions”

Lauri Mansikkaniemia Department of Cardiology, Heart and Lung Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, FinlandCorrespondence[email protected]
,
Hirokazu Miyashitab Department of Cardiology, Shonan Kamakura General Hospital, Kamakura, Japan
,
Juha Sinisaloa Department of Cardiology, Heart and Lung Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
,
Juhani Stewarta Department of Cardiology, Heart and Lung Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
&
Petri Lainea Department of Cardiology, Heart and Lung Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
Article: 2373102 | Received 14 May 2024, Accepted 23 Jun 2024, Published online: 02 Jul 2024

References

  • Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391(10115):31–40. doi: 10.1016/S0140-6736(17)32714-9.
  • Rajkumar CA, Foley MJ, Ahmed-Jushuf F, et al. A placebo-controlled trial of percutaneous coronary intervention for stable angina. N Engl J Med. 2023;389(25):2319–2330. doi: 10.1056/NEJMoa2310610.
  • Khan S, Fawaz S, Simpson R, et al. The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: the ORBITA-CTO pilot study design and protocol. Front Cardiovasc Med. 2023;10:1172763. doi: 10.3389/fcvm.2023.1172763.
  • Boden WE, O'Rourke RA, Teo KK, et al. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial). Am J Cardiol. 2009;104(1):1–4. doi: 10.1016/j.amjcard.2009.02.059.
  • Stergiopoulos K, Boden WE, Hartigan P, et al. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med. 2014;174(2):232–240. doi: 10.1001/jamainternmed.2013.12855.
  • Khan MF, Brilakis ES, Wendel CS, et al. Comparison of procedural complications and in-hospital clinical outcomes between patients with successful and failed percutaneous intervention of coronary chronic total occlusions: a meta-analysis of observational studies. Catheter Cardiovasc Interv. 2015;85(5):781–794. doi: 10.1002/ccd.25712.
  • Kuno T, Ohata T, Nakamaru R, et al. Long-term outcomes of periprocedural coronary dissection and perforation for patients undergoing percutaneous coronary intervention in a Japanese multicenter registry. Sci Rep. 2023;13(1):20318. doi: 10.1038/s41598-023-47444-7.
  • Brilakis ES, Banerjee S, Karmpaliotis D, et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2015;8(2):245–253. doi: 10.1016/j.jcin.2014.08.014.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.